Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
Friday, 29 March 2024
Authored Items
Alzheimer’s Prevention Clinic: A New Approach to Disease Management Shows Benefits
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Pro and Con: Do Cognitive-Enhancing Activities Prevent Dementia?
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Idalopirdine Improves Cognition in Patients with Moderate Alzheimer’s Disease
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Alzheimer’s Disease/Dementia
Brain–Computer Interfaces Breaking New Ground in Patients with Neurologic Disability
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Brain Technology
The Causes and Consequences of Misdiagnosing Multiple Sclerosis
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Multiple Sclerosis
Simvastatin plus Vitamin D May Prevent Headaches in Adults with Migraines
Chase Doyle
VBCN - November 2016 Volume 3, No 3
in
Migraine Update
Neuro-Oncology Update for Neurologists
Chase Doyle
Web Exclusives
in
Neurology News
Better Care Is Less Costly; Quality Improvement Through Process Management
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Value in Neurology
Dichlorphenamide Improves Outcomes in Periodic Paralysis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Ocrelizumab Promotes No Evidence of Disease Activity in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Emerging Disease-Modifying Therapies for Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Emerging Therapies
Experts Debate the Benefits of Early Aggressive Therapy in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Multiple Sclerosis
Natalizumab Shows Significant Benefit in Slowing Disability Progression in Multiple Sclerosis
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Multiple Sclerosis
Individualizing Antiepileptic Drug Therapy: Consider the Side Effects
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Epilepsy/Seizures
Poor Response to Acute Migraine Treatment May Lead to Headache Progression
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Migraine Update
Magnetic Stimulation Decreases "Freezing" Episodes in Parkinson's Disease, Improves Patient Outcomes
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Parkinson’s Disease
Zika Virus Linked to Guillain-Barré Syndrome
Chase Doyle
VBCN - July 2016 Volume 3, No 2
in
Neurologic Disorders Update
Decision Aids: Facilitating Communication with Cancer Survivors
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Survivorship
Multidisciplinary Teamwork Needed for Survivorship Care
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Survivorship
Adverse Events Associated with Tyrosine Kinase Inhibitors Carry High Economic Burden
Chase Doyle
VBCC - May 2016, Vol 7, No 4
in
Value in Oncology
Imatinib Can Be Safely Discontinued in Patients with Deep Molecular Response
Chase Doyle
Web Exclusives
in
Hematologic Cancers
Cost of Care Not Linked to Improved Survival for Elderly Patients with Myelodysplastic Syndromes
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Value in Oncology
Improving Survivorship Care: A Patient Advocate's Prescription
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Survivorship
Impact of Financial Toxicity on Health-Related Quality of Life
Chase Doyle
VBCC - April 2016, Vol 7, No 3
in
Value in Oncology
Anthem’s Response to Survivorship Medicine: Reimbursement Based on Care Coordination and Patient Outcomes
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Survivorship
New Survey: Physicians Are Not Addressing Financial Distress in Patients with Multiple Myeloma
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Value in Oncology
Clinical Advances with Targeted Therapies for CLL Also Carry High Economic Burden
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Value in Oncology
A New Paradigm for Survivorship Care: Assessing the Patient’s Priorities
Chase Doyle
VBCC - March 2016, Vol 7, No 2
in
Survivorship
Value-Based Purchasing: Implications for Hematology
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Clinical Pathways and the Oncology Medical Home: First Steps to Value-Based Patient Care
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Redesigning the Payment Model for Acute Leukemia: Benefits and Challenges of the Episode-of-Care Model
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Measuring Value in Healthcare to Improve Quality
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Value in Oncology
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia
Chase Doyle
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Treating Sexual Dysfunction in Breast Cancer Survivors
Chase Doyle
VBCC - December 2015, Vol 6, No 11
in
Survivorship
Addressing Fertility Issues in Patients with Breast Cancer
Chase Doyle
VBCC - December 2015, Vol 6, No 11
in
Survivorship
Immunotherapies Steal the Show at ASCO 2015
Chase Doyle
VBCC - September 2015, Vol 6, No 8
in
Immunotherapy
Communication with Oncologists, Not Cost, Tops Patients’ Value Priorities
Chase Doyle
VBCC - September 2015, Vol 6, No 8
in
Value in Oncology
Rheumatology Fellows Shine in Florida: Research Highlights from NYRIF
Chase Doyle
VBCR - August 2015, Volume 4, No 4
in
Rheumatology Update
Inhaled Levodopa Provides Rapid Motor Improvements in Patients with Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Racial Disparities in Daily Activities After Stroke: Why Are Outcomes Worse in African Americans?
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Stroke
Sodium Valproate Reduces Pain in Pediatric Patients with Migraine
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Headache Management
Patient-Reported Outcomes in Secondary-Progressive Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Multiple Sclerosis
Best Practices in Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Multiple Sclerosis
Study Identifies Predictors of Outcomes in Patients with Mild Ischemic Stroke
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Stroke
Antipsychotics Increase Mortality in Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Screening Tool Predicts Risk for Dementia in Patients with Parkinson’s Disease
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Parkinson’s Disease
Increased Use of Sodium Channel Blockers May Reduce Costs in Partial-Onset Seizures
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
Parameters Affecting Treatment Decisions for Patients with Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
Sex Differences in Response to Tramadol Therapy
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
Unemployment Status Linked to Disability in Secondary-Progressive Multiple Sclerosis
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Health Economics
New Biomarkers Identify Chronic Pain Severity
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
Opioid Abuse Risk in Patients with Chronic Pain
Chase Doyle
VBCN - July 2015 Volume 2, No 2
in
Chronic Pain
Value Propositions in Oncology: The Physician Perspective
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
Anthem’s Clinical Pathways Demonstrate Value: The Payer Perspective
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
The Search for Value-Based Healthcare Delivery: The Agenda for Oncology
Chase Doyle
VBCC - July 2015, Vol 6, No 6
in
Value in Oncology
Reinventing Disease: A Systematic Approach to Translational Rheumatology
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Microglial Modulation: The Key to Treating Neuroinflammatory Disease
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Biosimilars and Dose Reductions Will Reduce the Costs of Biologics
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Lupologists Seek “Holy Grail” of Biomarkers
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Psoriatic Arthritis: Treating the Totality of Disease
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Tendinopathy at the Molecular Level: A Translational Journey
Chase Doyle
VBCR - June 2015, Volume 4, No 3
in
CCR Conference Highlights
Combination Immunotherapy Superior to Monotherapy in Patients with Melanoma
Chase Doyle
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Inpatient Costs for MS-Related Disease Relapse Higher for Males Than for Females
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Teriflunomide Demonstrates Significant Efficacy in Patients with Multiple Sclerosis
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Multiple Sclerosis
High Doses of Biotin Improve Physical, Neurologic Function in Patients with Progressive Multiple Sclerosis
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Multiple Sclerosis
Nonpsychoactive Cannabidiol Helps Children with Severe Epilepsy
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Epilepsy Management
Should Neurologists Prescribe Opioids for the Management of Chronic Pain?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Side Effect Management
Preventing Disease Relapse in Patients with Multiple Sclerosis May Reduce Associated Costs
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Inpatient Care Coordination Could Impact Clinical Outcomes, Duration of Hospital Stays
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Health Economics
Differences in Disease Burden Examined
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Parkinson’s Disease
Is the Science of Stem Cells Ready?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Clinical Trials
Should Whole-Exome Sequencing Be Integrated into Neurologic Care?
Chase Doyle
VBCN - May 2015 Volume 2, No 1
in
Personalized Medicine in Neurology
Choice of Hospital for Readmissions Influences Mortality Risk in Men with Urologic Cancer
Chase Doyle
VBCC - April 2015, Vol 6, No 3
in
Economics of Cancer Care
Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with Renal-Cell Carcinoma
Chase Doyle
VBCC - April 2015, Vol 6, No 3
in
Economics of Cancer Care
Regorafenib in Metastatic Colorectal Cancer: High Cost with Little Benefit
Chase Doyle
VBCC - March 2015, Vol 6, No 2
in
Economics of Cancer Care
Increasing the Understanding of Rheumatic Diseases
Chase Doyle
VBCR - February 2015, Volume 4, No 1
in
Practice Management
Brentuximab Cost-Effective After Transplant
Chase Doyle
VBCC - February 2015, ASH 2014 Highlights
in
Lymphoma
Economic Value of Survival Gains for MDS Could Exceed $100 Billion
Chase Doyle
VBCC - February 2015, ASH 2014 Highlights
in
Health Economics
Brentuximab Vedotin Cost-Effective After Transplant in Relapsed/Refractory Hodgkin Lymphoma
Chase Doyle
VBCC - February 2015, Vol 6, No 1
in
Economics of Cancer Care
Top 10 Reasons Against Routine Genomic Profiling of Tumors in Patient Care
Chase Doyle
VBCC - February 2015, Vol 6, No 1
in
Personalized Medicine
Value Is Not “Code” for Cost Reduction
Chase Doyle
VBCC - November 2014, Vol 5, No 9
in
Economics of Cancer Care
Symptom Management Drives Value in Oncology
Chase Doyle
VBCC - November 2014, Vol 5, No 9
in
Economics of Cancer Care
Last modified: November 20, 2014
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines